Abstract
Based on molecular docking analysis, nine alkyl 3,4-di-O-caffeoyl- quinates have been designed. Started from 3,4-di- O-caffeoylquinic acid (3,4-DCQA), all the compounds have been synthesized using thionylchloride as coupling reagent with yields of 56%-72%. By applying plaque reduction assay, the anti-respiratory syncytial virus (RSV) activities of all the compounds were evaluated. The IC50 values of all the derivatives were 2.9 to 7.8 times less than that of 3,4-DCQA itself. Isopropyl 3,4-Di-O-caffeoyl quinate (LS-4) was confirmed as the most active compound with IC50 value of 0.3 μM. It was indicated that hydrophobic groups with 2 to 4 carbon chain length were optimal for the enhancement of anti-RSV activity. Interestingly, all the derivatives showed greater cytotoxicity than 3,4-DCQA. Except LS-5, LS-6 and LS-9, all the derivatives have less toxicity than ribavirin. Furthermore, the stabilities of LS-4 in water, artificial gastric juice (AGJ), and artificial intestinal juice were evaluated, respectively. It was shown that LS-4 is stable in AGJ with the hydrolysis rate of 24.9% after 6 hours incubation at 37°C.
Highlights
Human respiratory syncytial virus (RSV) is a member of the Paramyxoviradae
Approximately 95% of children have been exposed to RSV by 2 years of age, and 100% of children have been exposed by the time they reach adulthood [1]
Because the immune response to RSV infection is not protective, RSV infections may re-occur throughout adulthood [2], and can occur as a co-infection with other respiratory pathogens, leading to exacerbated symptoms [3,4]
Summary
Human respiratory syncytial virus (RSV) is a member of the Paramyxoviradae. Exposure to RSV is essentially universal for those under 2 years of age and re-infection is common, a consequence of an incomplete immune response of limited durability. Approximately 95% of children have been exposed to RSV by 2 years of age, and 100% of children have been exposed by the time they reach adulthood [1]. Because the immune response to RSV infection is not protective, RSV infections may re-occur throughout adulthood [2], and can occur as a co-infection with other respiratory pathogens, leading to exacerbated symptoms [3,4]. High levels of mortality are associated with outbreaks of RSV in bone marrow transplant units [8,9]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.